Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Virbac SA

VRBCFPNK
Healthcare
Drug Manufacturers - General
$431.80
$85.80(24.80%)
U.S. Market opens in 17h 12m

Virbac SA (VRBCF) Stock Overview

Explore Virbac SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.6B
P/E Ratio19.07
EPS (TTM)$20.31
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$350.76
3 Months$349.82
1 Year Target$346.74

VRBCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Virbac SA (VRBCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $346.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.07 and a market capitalization of 3.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
24.80%
5-Day Change
24.80%
1-Month Change
24.80%
3-Month Change
24.80%
6-Month Change
24.80%
Year-to-Date (YTD) Change
24.80%
1-Year Change
33.05%
3-Year Change
7.95%
5-Year Change
67.36%
All-Time (Max) Change
519.07%

Contact Information

33 4 92 08 71 00
13e rue LID - BP 27, Carros, NaN, 06511

Company Facts

63,650 Employees
IPO DateApr 17, 2013
CountryFR
Actively Trading

Frequently Asked Questions